Schoumacher M,El-Marjou F,Laé M,et al.Conditional expression of fascin increases tumor progression in a mouse model of intestinal cancer[J].Eur J Cell Biol,2014,93(10-12):388-395.
[4]
McGregor MJ,Fadhil W,Wharton R,et al.Aberrant P53 expression lacks prognostic or predictive significance in colorectal cancer:results from the VICTOR Trial[J].Anticancer Res,2015,35(3):1641-1645.
Omer A,Mehmet K,Levent Y,et al.Fascin and EMMPRIN expression in primary mucinous tumors of ovary:a tissue microarray study[J].Pathol Res Pract,2014,210(12):934-938.
Rahrotaban S,Azmoudeh F,Kiyani SM.Fascin expression in pleomorphic adenoma and mucoepidermoid carcinoma[J].Dent Res J(Isfahan),2014,11(3):370-374.
[10]
Ricordel C,Labalette-Tiercin M,Lespagnol A,et al.EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome:report of two cases and review of the literature[J].Lung Cancer,2015,87(1):80-84.
[11]
Arfaoui A,Douik H,Kablouti G,et al.Role of p53 codon72 SNP in breast cancer risk and anthracycline resistance[J].Anticancer Res,2015,35(3):1763-1769.
